Stem Cell-Based Therapy for Coronavirus Disease 2019.,Stem Cells and Development

当前位置： X-MOL 学术 › Stem Cells Dev. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Stem Cell-Based Therapy for Coronavirus Disease 2019.
Stem Cells and Development ( IF 2.5 ) Pub Date : 2020-05-22 , DOI: 10.1089/scd.2020.0071
Robert Chunhua Zhao ₁

Affiliation

The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation.

更新日期：2020-05-22

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11